Skip to main content
. Author manuscript; available in PMC: 2023 Sep 1.
Published in final edited form as: J Am Geriatr Soc. 2022 May 25;70(9):2719–2722. doi: 10.1111/jgs.17895

Figure 2.

Figure 2.

Meta-analysis of the effects of novel glucose-lowering drugs on the risk of vascular dementia in participants with or without type 2 diabetes. OR, odds ratio; CI, confidence interval; DPP-4 inhibitors, dipeptidyl peptidase-4 inhibitors; GLP-1RAs, glucagon-like peptide-1 receptor agonists; SGLT2 inhibitors, sodium-glucose co-transporter-2 inhibitors.